AS
Angelo Scuotto
R&D Director at Vaxinano
View Angelo's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
R&D Director
May 2019 - Present · 5 years and 7 months
BIFINOVE SAS
R&D Project Manager
Jul 2015 - May 2019 · 3 years and 10 months
BIFINOVE/ EA3610 Université Lille 2
Doctorant Cifre (Ea3610-Pathogenèse Virale Du Diabète De Type 1// Bifinove Sas)
Sep 2011 - Jun 2015 · 3 years and 9 months
Company Details
11-50 Employees
Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics. The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
Year Founded
2016
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research, Biotechnology research and development, Research and testing, IT, Internet, R&D
HQ Location
84, Rue du Docteur Yersin Loos, Hauts-de-France 59120, FR
Keywords
BiotechnologyNanotechnologyVaccineAnimal HealthHuman Health
Discover More About Cleveland Clinic

Find verified contacts of Angelo Scuotto in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.